Perampanel Tablet, Film Coated
Product Images NDC 0480-7068

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Perampanel (NDC 0480-7068). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

New (Image 1)

New (Image 1)
Chemical structure of Perampanel, showing the arrangement of its heterocyclic and aromatic rings with nitrogen and oxygen atoms as part of the molecular framework.*
FDA Label Image

12 (Image 10)

12 (Image 10)
Label for Perampanel tablets 12 mg, film-coated oral tablets. The label shows the NDC 0480-7068-56 and indicates the package contains 30 tablets. Manufactured by Teva Pharmaceuticals, Inc., the label includes storage instructions and dispensing information, along with a lot/expiration coding area.*
FDA Label Image

1 (Image 2)

1 (Image 2)
A bar chart displaying median percent reduction in seizure frequency from baseline across three studies comparing placebo and Perampanel at various mg/day doses. Values show higher seizure reduction percentages with Perampanel versus placebo, with statistical significance indicated. The x-axis labels study groups and dosing; the y-axis shows percent reduction ranging from 0% to 50%.*
FDA Label Image

2 (Image 3)

2 (Image 3)
A bar chart showing the proportion of patients (%) across five different categories ranging from 'Worse' to '75 to <100'. Data compares Placebo and Perampanel at doses of 4 mg/day, 8 mg/day, and 12 mg/day, with a key distinguishing each group by different fill patterns and shading.*
FDA Label Image

3 (Image 4)

3 (Image 4)
A bar chart comparing the proportion of patients (%) across treatment groups Placebo and Perampanel (N=81 each) within different ranges of response categories: Worse, 0 to <25, 25 to <50, 50 to <75, and 75 to 100. The chart visually presents treatment group data with Perampanel bars hatched and Placebo bars solid white.*
FDA Label Image

2 (Image 5)

2 (Image 5)
Perampanel Tablets 2 mg film-coated oral tablets packaging label. The label indicates a quantity of 30 tablets, NDC 0480-7062-56, manufactured by Teva Pharmaceuticals, Inc. It includes storage instructions, prescribing information references, and a note to dispense the accompanying Medication Guide to each patient. The label includes manufacturing details and lot/expiration coding area.*
FDA Label Image

4 (Image 6)

4 (Image 6)
Perampanel 4 mg tablets film-coated oral dosage form in a 30 tablet package. Label includes dosage strength, manufacturer Teva Pharmaceuticals, Inc., storage instructions, dispensing information, and lot/expiration coding area. The label uses black and orange text on a white background with green accent.*
FDA Label Image

6 (Image 7)

6 (Image 7)
Label for Perampanel Tablets 6 mg oral film-coated tablets by Teva Pharmaceuticals, Inc. The label includes dosage information, storage instructions (20 to 25°C, with allowance to 15 to 30°C), and packaging details: 30 tablets per container. Manufactured in Croatia by Pliva Hrvatska d.o.o., labeled with NDC 0480-7065-56 and includes pharmacist dispensing instructions.*
FDA Label Image

8 (Image 8)

8 (Image 8)
Perampanel 8 mg film-coated tablets package label by Teva Pharmaceuticals, Inc. The label includes storage instructions, dispensing guidance, and a note to pharmacists to provide the Medication Guide to patients. The package contains 30 oral tablets, NDC 0480-7066-56, with manufacturing and distribution information.*
FDA Label Image

10 (Image 9)

10 (Image 9)
Label for Perampanel Tablets 10 mg, film-coated oral tablets from Teva Pharmaceuticals, Inc. The label includes dosage information, storage instructions, manufacturer details, and a note to dispense the accompanying Medication Guide. Packaging contains 30 tablets with NDC 0480-7067-56.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.